BackTeva- Pharmaceutical Industries Overview
Teva- Pharmaceutical Industries Ltd. - ADR

Teva- Pharmaceutical Industries P/E Ratio

Teva- Pharmaceutical Industries (TEVA) has a P/E ratio of 98.89, above the Healthcare sector average of 21.65.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

98.89

P/E Ratio

98.89

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

Teva- Pharmaceutical Industries (TEVA) FAQ

The latest P/E ratio for TEVA is 98.89. That is above the Healthcare sector average of 21.65. Investors often review this figure alongside Teva- Pharmaceutical Industries's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, TEVA currently prints 98.89 for P/E ratio, while the sector average sits near 21.65. That is roughly 356.9% above the sector mean. Large gaps often invite a closer look at Teva- Pharmaceutical Industries's growth, margins, and balance sheet.

A P/E ratio of 98.89 for Teva- Pharmaceutical Industries is not 'good' or 'bad' on its own. Compare it with the peer average (21.65) and with TEVA's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting TEVA's P/E ratio (98.89), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Teva- Pharmaceutical Industries's P/E ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.